Prevalence of SARS-CoV-2 Omicron Sublineages and Spike Protein Mutations Conferring Resistance against Monoclonal Antibodies in a Swedish Cohort during 2022-2023.

bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly

Evusheld (cilgavimab/tixagevimab) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/37894075

Frans Wallin; Johan Lennerstrand; Johan Lindh; Jonathan Haars; Martin Sundqvist; Navaneethan Palanisamy; Patrik EllstrÃ¶m; Paula MÃ¶lling; Rene Kaden

Oct 28, 2023